Descriptor English: | Metabolic Syndrome | ||||||
Descriptor Spanish: |
Síndrome Metabólico
| ||||||
Descriptor Portuguese: | Síndrome Metabólica | ||||||
Descriptor French: | Syndrome métabolique X | ||||||
Entry term(s): |
Cardiometabolic Syndrome Cardiometabolic Syndromes Cardiovascular Syndrome, Metabolic Cardiovascular Syndromes, Metabolic Dysmetabolic Syndrome X Insulin Resistance Syndrome X Metabolic Cardiovascular Syndrome Metabolic Syndrome X Metabolic Syndromes Metabolic X Syndrome Reaven Syndrome X Syndrome X, Dysmetabolic Syndrome X, Insulin Resistance Syndrome X, Metabolic Syndrome X, Reaven Syndrome, Cardiometabolic Syndrome, Metabolic Syndrome, Metabolic Cardiovascular Syndrome, Metabolic X Syndromes, Cardiometabolic Syndromes, Metabolic X Syndrome, Metabolic |
||||||
Tree number(s): |
C18.452.394.968.500.570 C18.452.625 |
||||||
RDF Unique Identifier: | https://id.nlm.nih.gov/mesh/D024821 | ||||||
Scope note: | A cluster of symptoms that are risk factors for CARDIOVASCULAR DISEASES and TYPE 2 DIABETES MELLITUS. The major components of metabolic syndrome include ABDOMINAL OBESITY; atherogenic DYSLIPIDEMIA; HYPERTENSION; HYPERGLYCEMIA; INSULIN RESISTANCE; a proinflammatory state; and a prothrombotic (THROMBOSIS) state. |
||||||
Allowable Qualifiers: |
BL blood CF cerebrospinal fluid CI chemically induced CL classification CN congenital CO complications DG diagnostic imaging DH diet therapy DI diagnosis DT drug therapy EC economics EH ethnology EM embryology EN enzymology EP epidemiology ET etiology GE genetics HI history IM immunology ME metabolism MI microbiology MO mortality NU nursing PA pathology PC prevention & control PP physiopathology PS parasitology PX psychology RH rehabilitation RT radiotherapy SU surgery TH therapy UR urine VE veterinary VI virology |
||||||
Previous Indexing: |
Insulin Resistance (1992-2001) Syndrome X (1996-2001) |
||||||
Public MeSH Note: | 2018; see METABOLIC SYNDROME X 2002-2017; for REAVEN SYNDROME X see INSULIN RESISTANCE 1998-2001 |
||||||
History Note: | 2018 (2002); for REAVEN SYNDROME X use INSULIN RESISTANCE 1998-2001 |
||||||
Related: |
Cardiometabolic Risk Factors
MeSH Diabetes Mellitus, Type 2 MeSH Microvascular Angina MeSH | ||||||
DeCS ID: | 36032 | ||||||
Unique ID: | D024821 | ||||||
NLM Classification: | WK 820 | ||||||
Documents indexed in the Virtual Health Library (VHL): | Click here to access the VHL documents | ||||||
Date Established: | 2002/01/01 | ||||||
Date of Entry: | 2001/07/25 | ||||||
Revision Date: | 2020/02/28 |
|
Metabolic Syndrome
- Preferred
Cardiometabolic Syndrome
- Related but not broader or narrower
Concept UI |
M0011433 |
Scope note | A cluster of symptoms that are risk factors for CARDIOVASCULAR DISEASES and TYPE 2 DIABETES MELLITUS. The major components of metabolic syndrome include ABDOMINAL OBESITY; atherogenic DYSLIPIDEMIA; HYPERTENSION; HYPERGLYCEMIA; INSULIN RESISTANCE; a proinflammatory state; and a prothrombotic (THROMBOSIS) state. |
Preferred term | Metabolic Syndrome |
Entry term(s) |
Cardiovascular Syndrome, Metabolic Cardiovascular Syndromes, Metabolic Dysmetabolic Syndrome X Insulin Resistance Syndrome X Metabolic Cardiovascular Syndrome Metabolic Syndrome X Metabolic Syndromes Metabolic X Syndrome Reaven Syndrome X Syndrome X, Dysmetabolic Syndrome X, Insulin Resistance Syndrome X, Metabolic Syndrome X, Reaven Syndrome, Metabolic Syndrome, Metabolic Cardiovascular Syndrome, Metabolic X Syndromes, Metabolic X Syndrome, Metabolic |
Concept UI |
M000678837 |
Scope note | A cluster of symptoms that are risk factors for CARDIOVASCULAR DISEASES and TYPE 2 DIABETES MELLITUS. The major components not only include metabolic dysfunctions of METABOLIC SYNDROME but also HYPERTENSION, and ABDOMINAL OBESITY. |
Preferred term | Cardiometabolic Syndrome |
Entry term(s) |
Cardiometabolic Syndromes Syndrome, Cardiometabolic Syndromes, Cardiometabolic |
We want your feedback on the new DeCS / MeSH website
We invite you to complete a survey that will take no more than 3 minutes.
Go to survey